Recently added articles from Pharma Marketletter:
EMEA lifts restrictions on prescribing Schwarz' Neupro.
Jun 08, 2009 ... The European Medicines Agency has recommended that the supply and treatment restrictions for Neupro (rotigotine transdermal patch), from German drugmaker Schwarz Pharma, be lifted. Neupro is currently indicated for the treatment of Parkinson's disease and restless legs syndrome ....
BioPartners withdraws MAA application for Biferonex.(Brief article)
Jun 08, 2009 ... Swiss biopharmaceutical firm BioPartners has withdrawn its application to the European Medicines Agency for Biferonex (interferon beta-1a), solution for injection, prefilled syringes for subcutaneous administration to treat patients with relapsing-remitting multiple sclerosis characterised ...
AstraZeneca seeks to extend EU indication of Seroquel to MDD.
Jun 08, 2009 ... Anglo-Swedish drug major AstraZeneca's application to have the treatment of recurrent depressive episodes in adult patients with major depressive disorder (MDD) added to the indications of its bipolar disorder and schizophrenia drug Seroquel XR (quetiapine fumarate) has been turned down by ...
Merckle creditors express woes.
Jun 08, 2009 ... According to a German newspaper report, circulated by Pharma Adhoc, exactly 61 creditor banks are involved in the restructuring of the Merckle empire. Also the Deutsche Apotheker- und Arztebank (Apobank) is among the financers of the deceased entrepreneur Adolf Merckle (Marketletters ...
Sanoif settles Medicaid price investigation.
Jun 08, 2009 ... French drug major Sanofi-Aventis' US subsidiary has announced a civil settlement with the Department of Justice and the Attorney's Office for the District of Massachusetts to resolve a Medicaid "best price" investigation involving one of its predecessor companies, Aventis Pharmaceuticals ...